U.S. Entertainment Stock News

In January 2026, CareDx issued earnings guidance for the fourth quarter and full year 2025, projecting approximately US$108,000,000 in quarterly revenue and about US$380,000,000 for the year, both showing double-digit year-over-year growth. This updated outlook highlights management’s confidence in the company’s current operating trajectory and signals stronger-than-previously-communicated business momentum. Next, we will examine how CareDx’s higher 2025 revenue guidance could shape the...

National Storage Affiliates Trust recently reported solid Q3 2025 results, with improved same-store revenue growth across most key markets and core FFO per share exceeding consensus expectations, while also preparing to release its Q4 2025 results in late February 2026. The company introduced a preferred equity investment program aimed at funding self-storage deals and deepening partnerships with former PRO operators, which management highlighted alongside its positive commentary on...

In recent weeks, Restaurant Brands International has attracted renewed attention as analysts at Barclays and RBC Capital reiterated positive views alongside expanding partnerships for Burger King operations in China and Asia. High-profile investor interest from Bill Ackman, combined with a franchise-focused model and ongoing investments in growth and debt reduction, is reinforcing confidence in the company’s long-term direction. With this backdrop and the new CPE partnership in China, we’ll...

Banner Corporation reported past fourth-quarter and full-year 2025 results, with net interest income, net income, and earnings per share all higher than a year earlier, alongside a regular US$0.50 per-share quarterly dividend declared for payment on February 13, 2026. Despite higher profitability, the quarter featured revenue below analyst expectations, muted loan growth, lower net charge-offs, and continued capital returns through share repurchases and dividends, giving a mixed picture of...

Why ICU Medical (ICUI) Is Back on Investors’ Radar ICU Medical (ICUI) is drawing fresh attention after recent commentary pointed to slower revenue growth than healthcare peers and an estimated 7.7% sales decline over the next 12 months, suggesting a tougher demand backdrop. See our latest analysis for ICU Medical. ICU Medical’s share price has pulled back 3.7% over the last day and 2.2% over the week, yet it still carries a 24.2% 3 month share price return and a weaker 1 year total...

Why the recent asset sales and filings matter for Global Net Lease Global Net Lease (GNL) has been in focus after completing sizable asset sales, including the McLaren Campus disposal, while continuing a portfolio sell down aimed at reducing leverage and clarifying recent regulatory filings. For you as an income focused investor, the combination of these asset disposals, ongoing balance sheet work, and the recent clarification around capital raising plans helps frame how GNL is repositioning...

Why Crown Holdings Is Back on Investors’ Radar Crown Holdings (CCK) is drawing fresh attention after a run of earnings beats, higher guidance, and a Q1 2025 share repurchase of $233 million, as investors look ahead to Q4 results and the company’s 2026 outlook. See our latest analysis for Crown Holdings. The share price at US$103.92 reflects a modest 1 day gain and a steady 90 day share price return of 4.88%, while the 1 year total shareholder return of 19.42% suggests momentum has been...

Commerce Bancshares (CBSH) stock action is being shaped by fresh fourth quarter results, including record revenues, solid earnings and share repurchases, as well as the completed FineMark acquisition that expands its wealth management and private banking reach. See our latest analysis for Commerce Bancshares. Those record fourth quarter numbers and the FineMark deal come after a mixed stretch for investors, with a 90 day share price return of 5.26% and a 1 year total shareholder return...

Why the latest guidance and analyst sentiment matter Butterfly Network (BFLY) has drawn fresh attention after guiding for at least 17% year over year revenue growth in the fourth quarter of 2025, with several brokerage firms reiterating positive views on the stock. For you as an investor, that combination of explicit growth guidance and supportive analyst commentary creates a clear focal point: how much confidence you place in Butterfly’s ability to translate handheld ultrasound adoption into...

What triggered the latest move in Tandem Diabetes Care (TNDM)? Rosen Law Firm has begun investigating Tandem Diabetes Care (TNDM) after allegations that the company shared misleading business information, tied to a voluntary correction for certain t:slim X2 insulin pumps. See our latest analysis for Tandem Diabetes Care. The legal investigation comes after a sharp reset in expectations, with a 1 month share price return of an 11% decline and a 1 year total shareholder return showing a 45.48%...

In recent days, New Fortress Energy has gained attention after outlining new partnerships, a South American expansion via a Brazilian deal, and progress on its LNG technology, while still contending with operational losses, high debt, and regulatory hurdles. An interesting angle for investors is how these growth-focused partnerships and technology advances are emerging alongside persistent questions about the company’s long-term financial resilience. We’ll now examine how the South American...

Oceaneering International overview after recent price move Oceaneering International (OII) has drawn attention after a recent share price move, with the stock last closing at $29.17. That puts its recent returns in focus for investors assessing risk and reward. Over the past month, the stock shows a 20.7% return, while the past 3 months reflect a 25.7% gain and the past year a 10.3% total return. These moves provide context for evaluating its current valuation and business profile. See our...

Why Xenon Pharmaceuticals is on investors’ radar today Xenon Pharmaceuticals (XENE) has been drawing fresh attention after recent share price swings. The stock closed at US$41.76 and has shown mixed returns over the past week, month, and past 3 months. See our latest analysis for Xenon Pharmaceuticals. While the recent 1-day share price return of 1.14% decline and 30-day share price return of 6.87% decline point to some cooling momentum, the 1-year total shareholder return of 4.53% and 5-year...

AMD (NasdaqGS:AMD) is working with Tata Consultancy Services to co-develop industry specific AI solutions for enterprise clients. Meta Platforms is adopting AMD's MI455X accelerators for its AI infrastructure, adding a large scale cloud customer to AMD's data center roster. AI related demand for AMD's data center chips is reported to be strong at a time when Intel is facing supply issues in key segments. For investors, these updates put AMD's AI push front and center. The company is known...

Why Hagerty Is Back on Investor Radar After Earnings and Partnership Updates Hagerty (HGTY) is in focus after reporting third quarter 2025 results that topped analyst expectations and after extending key agreements with Markel Group and Essentia Insurance through the end of 2028. See our latest analysis for Hagerty. After a strong third quarter, Hagerty’s recent 30 day share price return of an 8.97% decline contrasts with a 12.52% gain over 90 days. Its 1 year total shareholder return of...

Recent analyst commentary around Planet Fitness (PLNT) has focused on strong January membership trends, with surveys pointing to both legacy and new Black Card perks helping drive sign ups during this key period. See our latest analysis for Planet Fitness. Even with positive headlines around January sign ups and new Black Card perks, Planet Fitness shares have recently been under pressure, with a 30 day share price return of 13.39% decline and a year to date share price return of 13.91%...

CBRE Group (CBRE) is back on investors’ radar after being engaged by Bitzero Holdings as real estate broker for AI focused Nordic data center sites, emphasizing its push into digital infrastructure services. See our latest analysis for CBRE Group. While the share price has eased slightly in the last week, CBRE’s 30 day share price return of 2.74% and year to date share price return of 5.64% sit against a stronger backdrop, with total shareholder returns of 19.91% over one year and roughly 2x...

Rebranding to Marsh and Mercer's New Private Markets Tool Marsh & McLennan Companies (MRSH) has officially rebranded to Marsh, while its Mercer unit launched a private markets benchmarking platform that tackles fragmented data and highlights areas such as private credit and differentiated private equity strategies. See our latest analysis for Marsh & McLennan Companies. At a share price of $183.16, Marsh & McLennan Companies has had a mixed stretch, with a 1 day share price return of 1.39%...

Monarch partnership expansion puts DealCloud distribution in focus Intapp (INTA) is back on investors’ radar after Monarch Financial Technology Solutions expanded its partnership to resell DealCloud and support faster deployment across private capital market clients. See our latest analysis for Intapp. The Monarch expansion and upcoming February earnings webcast come after a mixed run for the shares, with a 30 day share price return of an 18.9% decline and a 1 year total shareholder return of...

Dividend announcement and what it means for Agree Realty stock Agree Realty (ADC) has put income front and center, with its board declaring a monthly common dividend of $0.262 per share and affirming the payout on its 4.25% Series A preferred stock. The new common dividend equates to $3.144 per share on an annualized basis, a 3.6% increase compared with the annualized $3.036 per share used in early 2025. Preferred holders receive $0.08854 per depositary share, or $1.0625 per year. See our...

In recent weeks, General Mills highlighted the return of Progresso Soup Drops for a second year, expanding the line with a new Variety Can featuring three classic soup flavors and a warming-in-mouth experience timed to National Soup Month and cold and flu season. At the same time, investors are watching for General Mills’ upcoming fiscal third-quarter earnings after the company previously beat profit expectations despite softer revenue and reaffirmed its full-year outlook. Next, we’ll...

Why Allegiant Travel Stock Is On Investor Radar Today Allegiant Travel (ALGT) has caught attention after recent trading, with the share price around $88.52 and returns mixed across different periods, including a loss over the past year and a gain over the past 3 months. See our latest analysis for Allegiant Travel. Recent trading has been choppy, with a 35.21% 3 month share price return contrasting with a 13.83% decline in 1 year total shareholder return. This suggests momentum has picked up...

Over the past two years, ePlus has reported stagnant sales, a forecast 2.1% revenue decline over the next 12 months, and a 5.5% annual drop in earnings per share, raising fresh concerns about its growth outlook. This combination of flat top-line performance and consistent earnings pressure points to deeper challenges in sustaining demand and profitability across the business. We’ll now explore how ePlus’s stagnating sales shape its investment narrative and what this could mean for investors...

In January 2026, Microchip Technology broadened its portfolio with new 600V gate drivers, PolarFire FPGA-based embedded video solutions, and JANPTX military-grade TVS devices, targeting industrial, consumer, and aerospace and defense applications. Together, these launches highlight Microchip’s push into higher-value power management, embedded vision, and high-reliability protection components that support electrification, advanced imaging, and mission-critical systems. Next, we’ll examine...